{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:44:58Z","timestamp":1792118698067,"version":"4.4.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.ejpb.2014.02.007","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T19:00:32Z","timestamp":1392750032000},"page":"30-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":93,"title":["Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)\u2013block-poly(d,l)-lactic-co-glycolic acid (PEG\u2013PLGA) nanoparticles for the treatment of schizophrenia"],"prefix":"10.1016","volume":"87","author":[{"given":"Justin","family":"Piazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Hoare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Molinaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Terpstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant","family":"Bhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Ravi","family":"Selvaganapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwati","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2014.02.007_b0005","first-page":"1","article-title":"Solanum tuberosum lectin-conjugated PLGA nanoparticles for nose-to-brain delivery: in vivo and in vitro evaluations","volume":"2","author":"Chen","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2014.02.007_b0010","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2014.02.007_b0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood\u2013brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2014.02.007_b0020","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S1359-6446(03)02903-9","article-title":"Nanotech approaches to drug delivery and imaging","volume":"8","author":"Sahoo","year":"2003","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2014.02.007_b0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ejpb.2014.02.007_b0030","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S1359-6446(02)02529-1","article-title":"Nasal drug delivery: new developments and strategies","volume":"7","author":"Illum","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejpb.2014.02.007_b0035","first-page":"18","article-title":"Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics","volume":"64","author":"Ereshefsky","year":"2003","journal-title":"J. Clin. Psychiat."},{"key":"10.1016\/j.ejpb.2014.02.007_b0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijpharm.2008.03.029","article-title":"Intranasal nanoemulsion based brain targeting drug delivery system of risperidone","volume":"358","author":"Kumar","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.02.007_b0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejpb.2010.04.013","article-title":"Freeze-dried chitosan\/pectin nasal inserts for antipsychotic drug delivery","volume":"75","author":"Luppi","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.02.007_b0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0928-0987(99)00061-5","article-title":"Bioavailability of apomorphine following intranasal administration of mucoadhesive drug delivery systems in rabbits","volume":"9","author":"Ugwoke","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2014.02.007_b0055","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1592\/phco.28.7.875","article-title":"Comparison of intranasal administration of haloperidol with intravenous and intramuscular administration: a pilot pharmacokinetic study","volume":"28","author":"Miller","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejpb.2014.02.007_b0060","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1016\/j.actbio.2011.07.025","article-title":"Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies","volume":"7","author":"Seju","year":"2011","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2014.02.007_b0065","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3109\/1061186X.2010.523787","article-title":"Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route","volume":"19","author":"Patel","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2014.02.007_b0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0168-3659(02)00363-2","article-title":"Nasal drug delivery \u2013 possibilities, problems and solutions","volume":"87","author":"Illum","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2014.02.007_b0075","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1016\/j.biomaterials.2006.01.038","article-title":"Lectin-conjugated PEG\u2013PLA nanoparticles: preparation and brain delivery after intranasal administration","volume":"27","author":"Gao","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2014.02.007_b0080","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1023\/A:1018826103261","article-title":"Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake","volume":"16","author":"Jaeghere","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2014.02.007_b0085","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01002469","article-title":"Lectin-binding pattern of neuroepithelial and respiratory epithelial cells in the mouse nasal cavity","volume":"21","author":"Lundh","year":"1989","journal-title":"Histochem. J."},{"key":"10.1016\/j.ejpb.2014.02.007_b0090","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/BF01460825","article-title":"Histochemical study of glycoconjugates in the nasal mucosa of the rat and guinea pig","volume":"24","author":"Pastor","year":"1992","journal-title":"Histochem. J."},{"key":"10.1016\/j.ejpb.2014.02.007_b0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpharm.2004.09.002","article-title":"PLA\u2013PEG particles as nasal protein carriers: the influence of the particle size","volume":"292","author":"Vila","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.02.007_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(03)00295-3","article-title":"Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(d,l-lactide-co-glycolide) nanoparticles","volume":"262","author":"Panyam","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.02.007_b0105","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1083\/jcb.63.2.430","article-title":"Protein degradation in cultured cells II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1","volume":"63","author":"Wibo","year":"1974","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejpb.2014.02.007_b0110","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1080\/02652040500273753","article-title":"Production of haloperidol loaded PLGA nanoparticles for extended controlled drug release of haloperidol","volume":"22","author":"Budhian","year":"2005","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2014.02.007_b0115","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0378-5173(01)00923-1","article-title":"Characterization of nanoparticle uptake by endothelial cells","volume":"233","author":"Davda","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.02.007_b0120","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/0024-3205(95)02240-5","article-title":"Studies on the metabolism of haloperidol (HP): the role of cyba in the production of the neurotoxic pyridinum metabolite HPP+ found in rat brain following administration of HP","volume":"57","author":"Igarashi","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.ejpb.2014.02.007_b0125","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1471-4159.1988.tb03005.x","article-title":"Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes","volume":"50","author":"Srivastava","year":"1988","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejpb.2014.02.007_b0130","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2014.02.007_b0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0196-9781(81)80019-8","article-title":"Effect of L-prolyl-L-leucyl-glycinamide (PLG) on neuroleptic-induced catalepsy and dopamine\/neuroleptic receptor bindings","volume":"2","author":"Chiu","year":"1981","journal-title":"Peptides"},{"key":"10.1016\/j.ejpb.2014.02.007_b0140","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0196-9781(99)00060-1","article-title":"Modulatory effects of PLG and its peptidomimetics on haloperidol induced catalepsy in rats","volume":"20","author":"Costain","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.ejpb.2014.02.007_b0145","doi-asserted-by":"crossref","first-page":"12157","DOI":"10.1073\/pnas.94.22.12157","article-title":"Loss of haloperidol induced gene expression and catalepsy in protein kinase A-deficient mice","volume":"94","author":"Adams","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejpb.2014.02.007_b0150","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0014-5793(89)80960-3","article-title":"The distribution of a dopamine D2 receptor mRNA in rat brain","volume":"253","author":"Weiner","year":"1989","journal-title":"Fed. Eur. Biochem. Soc. Lett."},{"key":"10.1016\/j.ejpb.2014.02.007_b0270","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.addr.2009.11.002","article-title":"Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging","volume":"64","author":"Veiseh","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2014.02.007_b0160","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejpb.2010.12.016","article-title":"Haloperidol-loaded polysorbate-coated polymeric nanocapsules increase its efficacy in the antipsychotic treatment in rats","volume":"77","author":"Benvegn\u00fa","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.02.007_b0165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2007.06.011","article-title":"Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles","volume":"346","author":"Budhian","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2014.02.007_b0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2217\/17435889.2.2.233","article-title":"Preparation and characterization of nanoparticles containing an atypical antipsychotic agent","volume":"2","author":"Muthu","year":"2007","journal-title":"Nanomedicine"},{"issue":"3","key":"10.1016\/j.ejpb.2014.02.007_b0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2217\/17435889.3.3.305","article-title":"Studies on biodegradable polymeric nanoparticles of risperidone: in vitro and in vivo evaluation","volume":"3","author":"Muthu","year":"2008","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2014.02.007_b0180","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1021\/bm050188k","article-title":"Synthesis and characterization of mPEG\u2013PLA prodrug micelles","volume":"6","author":"Hans","year":"2005","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2014.02.007_b0185","first-page":"477","article-title":"Quantifying drug release from PLGA nanoparticulates","volume":"37","author":"Corrigan","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.02.007_b0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00498552","article-title":"Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain","volume":"299","author":"\u00d6hman","year":"1977","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.ejpb.2014.02.007_b0195","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejpb.2014.02.007_b0200","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/BF02246184","article-title":"Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability","volume":"120","author":"Hoffman","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejpb.2014.02.007_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms2624","article-title":"Impaired endolysosomal function disrupts Notch signalling in optic nerve astrocytes","volume":"4","author":"Valapala","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejpb.2014.02.007_b0210","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2014.02.007_b0215","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1039\/C2BM00132B","article-title":"A once-a-day dosage form for the delivery of insulin through the nasal route: in vitro assessment and in vivo evaluation","volume":"1","author":"Nazar","year":"2013","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.ejpb.2014.02.007_b0220","doi-asserted-by":"crossref","first-page":"15511","DOI":"10.1073\/pnas.0807656105","article-title":"Blood\u2013brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity","volume":"105","author":"Fabis","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejpb.2014.02.007_b0225","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3109\/10611869808997870","article-title":"Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?","volume":"5","author":"Mathison","year":"1998","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ejpb.2014.02.007_b0230","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.addr.2011.12.006","article-title":"Polymeric nanoparticles for drug delivery to the central nervous system","volume":"64","author":"Patel","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2014.02.007_b0235","first-page":"1322","article-title":"Advantageous nasal drug delivery system: a review","volume":"2","author":"Chhajed","year":"2011","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"10.1016\/j.ejpb.2014.02.007_b0240","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1007074420772","article-title":"Inflammatory mediators and modulation of blood\u2013brain barrier permeability","volume":"20","author":"Abbott","year":"2000","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejpb.2014.02.007_b0275","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood\u2013brain barrier: bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx: J. Am. Soc. Exp. R NeuroTher."},{"key":"10.1016\/j.ejpb.2014.02.007_b0250","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/cne.901720409","article-title":"Projections from the amygdaloid complex and adjacent olfactory structures to the entorhinal cortex and to the subiculum in the rat and cat","volume":"172","author":"Krettek","year":"1977","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejpb.2014.02.007_b0255","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S1471-1931(00)00019-7","article-title":"Molecular effects of dopamine on striatal-projection pathways","volume":"23","author":"Geffen","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejpb.2014.02.007_b0260","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrn1349","article-title":"Glycans and neural cell interactions","volume":"5","author":"Kleene","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejpb.2014.02.007_b0265","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.polymertesting.2011.06.009","article-title":"Comparative study on the enzymatic degradation of poly(lactic-co-glycolic acid) by hydrolytic enzymes based on the colorimetric quantification of glycolic acid","volume":"30","author":"Kemme","year":"2011","journal-title":"Polym Test."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114000526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114000526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T23:00:08Z","timestamp":1648335608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641114000526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0939641114000526"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.02.007","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)\u2013block-poly(d,l)-lactic-co-glycolic acid (PEG\u2013PLGA) nanoparticles for the treatment of schizophrenia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}